Explore: Healthtech Infrastructure · Digital Health · Medtech · Seed · Series A
DNA VC II
DNA Capital
DNA Capital is a global healthcare investment firm that partners with exceptional founders and teams across early to late stages to build leading healthcare and healthtech businesses. Operating from offices in São Paulo, Brazil, and San Francisco, USA, the firm focuses on high-quality, ethical, and humane products and services throughout the healthcare sector. They provide capital, experienced partners, operators, and a network of advisors to help portfolio companies thrive.
DNA VC II (DNA Capital) invests at seed and Series A, focuses on Healthtech Infrastructure, Digital Health and Medtech, backs founders in Brazil.
Stages
Sectors
Geographies
Headquarters
Brazil
🔒 Team & partners
Sign in to view🔒 Live funding signals
Sign in to view🔒 Contacts
Sign in to viewSign in to see DNA VC II's full profile
Team & partners, portfolio, live funding signals and contacts. Free account, Google sign-in.
Create free accountVerified 12 May 2026 · Sources: company website, Fusion42 review
Frequently asked questions
- What does DNA VC II invest in?
- DNA VC II invests in Healthtech Infrastructure, Digital Health and Medtech at the seed and series-a stages.
- Which geographies does DNA VC II focus on?
- DNA VC II focuses on Brazil, and is headquartered in Brazil.